Zobrazeno 1 - 10
of 36
pro vyhledávání: '"K. Skinningsrud"'
Autor:
Bernd Stegmayr, G. Jakobsson, K. Skinningsrud, Folke Lithner, Sven-Ola Hietala, G. Holmberg, Stefan Lundqvist
Publikováno v:
Acta Radiologica. 39:362-367
Purpose: To evaluate the possible nephrotoxic effects of iohexol in patients with normal and impaired renal function. Material and Methods: A prospective urographic study using iohexol (50 ml, 300 mg I/ml) was performed in 100 patients, 63 with impai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47296ad24388eef104d142b69ef860d
https://doi.org/10.1080/02841859809172445
https://doi.org/10.1080/02841859809172445
Publikováno v:
European Radiology. 7:S127-S130
Iopentol (Imagopaque, Nycomed Imaging AS, Oslo, Norway) 300 mg.l/ml was compared with iopromide (Ultravist, Schering AG. Berlin, Germany) 300 mg I/ml in pediatric angiocardiography in 97 children (48 and 49 patients, mean age 2.8 and 4.1 years in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a518bfeaa6cf3bc0ed62e58be8fd541b
https://doi.org/10.1007/pl00006878
https://doi.org/10.1007/pl00006878
Publikováno v:
European Radiology. 7:S123-S126
A non-ionic, monomeric, low-osmolar contrast medium, iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) has been compared with iohexol (Omnipaque®, Nycomed Imaging AS, Oslo, Norway) in a double-blind, randomized, parallel-group trial in child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e205ef722317b41c0ce51e15428ad41c
https://doi.org/10.1007/pl00006877
https://doi.org/10.1007/pl00006877
Publikováno v:
European Radiology. 7:S140-S144
The aim of the trial was to evaluate and compare the safety and efficacy of iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) and amidotrizoate (Peritrast®, Kohler Pharma, Alsbach, Germany), both 300 mg I/ml initially, but diluted to 2 % (v/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d64af4f3a8ac77c9e25391dcac4ccdc
https://doi.org/10.1007/pl00006881
https://doi.org/10.1007/pl00006881
Autor:
J. Fairhurst, R. Svihus, O. Brekke, K. Tveit, J. Grellet, G. Jenssen, A.-N. Dardenne, K. Skinningsrud, L. Lemaitre
Publikováno v:
Clinical Radiology. 50:44-48
The purpose of the present phase IV multicentre trial was to evaluate general patient tolerance to Omnipaque ® 350 mgI/ml (iohexol) supplied in polypropylene containers compared to that of the same product supplied in routinely used glass vials, wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc09a77cfa40dd75bfb9ebcb450ff5b5
https://doi.org/10.1016/s0009-9260(05)82964-2
https://doi.org/10.1016/s0009-9260(05)82964-2
Publikováno v:
Acta Radiologica. 35:619-625
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9921f252b7474a0fd3a9f25a655d5989
https://doi.org/10.3109/02841859409173333
https://doi.org/10.3109/02841859409173333
Publikováno v:
Acta Radiologica. 35:619-625
The addition of sodium to nonionic contrast media has reduced the incidence of arrhythmias in animal models. The influence on cardiac function and safety of sodium addition to the nonionic contrast medium iohexol (Omnipaque) was studied in a randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ddb4bd70d3fb980e17d460bb18d847
https://doi.org/10.1080/02841859409173333
https://doi.org/10.1080/02841859409173333
Publikováno v:
Acta Radiologica. 33:485-489
It has recently been claimed that lack of sodium in nonionic contrast media may increase the risk of ventricular arrhythmias during coronary angiography. Thus, the influence of sodium addition to the nonionic contrast medium iohexol was studied in 75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131e75c57fce3f4fc338eb44c04a4b52
https://doi.org/10.1080/02841859209172042
https://doi.org/10.1080/02841859209172042
Publikováno v:
European radiology. 7
A non-ionic, monomeric, low-osmolar contrast medium, iopentol (Imagopaque, Nycomed Imaging AS, Oslo, Norway) has been compared with iohexol (Omnipaque, Nycomed Imaging AS, Oslo, Norway) in a double-blind, randomized, parallel-group trial in children.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f39d0d7fb054aefeb1467116f54a82e8
https://pubmed.ncbi.nlm.nih.gov/9204353
https://pubmed.ncbi.nlm.nih.gov/9204353
Publikováno v:
European radiology. 7
The aim of the study was to evaluate and compare the hemodynamic and electrocardiographic effects following injection of the non-ionic, low- osmolar contrast medium iopentol (Imagopaque® 350, Nycomed Imaging AS, Oslo, Norway) and the ionic, hyper-os
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe5eaaa8e02c37781661161769ee8a9
https://pubmed.ncbi.nlm.nih.gov/9204361
https://pubmed.ncbi.nlm.nih.gov/9204361